Immunocytochemical detection and phenotypic characterization of micrometastatic tumour cells in bone marrow of patients with prostate cancer

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Urological research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF00431541PMID 7521088
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improved section adhesion for immunocytochemistry using high molecular weight polymers of l-lysine as a slide coating

  2004cited by this paper
• Light microscopical detection of leukocyte cell surface antigens with a one-nanometer gold probe

  2004cited by this paper
• The Catalog of Human Cytokeratins: Patterns of Expression in Normal Epithelia, Tumors and Cultured Cells Review

  2004cited by this paper
• Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumour cells

  2004cited by this paper
• Reprints and Subscriptions Permissions

  2003cited by this paper
• Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients.

  1992influential reference
• Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.

  1991influential reference
• Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells.

  1991influential reference
• Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance.

  1991influential reference
• Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance.

  1990cited by this paper
• Monoclonal antibody that defines the prostate specific antigen

  1989cited by this paper
• Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.

  1988cited by this paper
• Biological characterization and oncogene expression in human colorectal carcinoma cell lines

  1988cited by this paper
• Expression of simple epithelial type cytokeratins in stratified epithelia as detected by immunolocalization and hybridization in situ

  1988cited by this paper
• Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.

  1987influential reference
• Cytoskeletal components of lymphoid organs

  1987cited by this paper
• Immunohistochemical investigation of different cytokeratins and vimentin in the prostate from the fetal period up to adulthood and in prostate carcinoma.

  1987cited by this paper
• Cytoskeletal components of lymphoid organs. I. Synthesis of cytokeratins 8 and 18 and desmin in subpopulations of extrafollicular reticulum cells of human lymph nodes, tonsils, and spleen.

  1987cited by this paper
• Immunoultrastructural demonstration of prostatic acid phosphatase isoenzyme 2 in prostatic carcinoma.

  1986cited by this paper
• Characterization of monoclonal antibodies raised against the prostatic cancer cell line PC‐82

  1986cited by this paper
• The ultrastructural localization of prostatic specific antigen and prostatic acid phosphatase in hyperplastic and neoplastic human prostates.

  1985cited by this paper
• Immunoelectron microscopic demonstration of prostatic acid phosphatase in human hyperplastic prostate

  1985cited by this paper
• Immunoperoxidase localization of prostatic antigens. Comparison of primary and metastatic sites.

  1984cited by this paper
• Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies.

  1984cited by this paper
• Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

  1984cited by this paper
• LNCaP model of human prostatic carcinoma.

  1983cited by this paper
• Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

  1983cited by this paper
• The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells.

  1982cited by this paper
• Applications of immunocolloids in light microscopy. Preparation of protein A-silver and protein A-gold complexes and their application for localization of single and multiple antigens in paraffin sections.

  1982cited by this paper
• Monoclonal cytokeratin antibodies that distinguish simple from stratified squamous epithelia: characterization on human tissues.

  1982cited by this paper
• Localization of gold in biological tissue

  1981cited by this paper
• Prostatic‐specific antigen: An immunohistologic marker for prostatic neoplasms

  1981cited by this paper
• Ficoll-isopaque gradients for the determination of density distributions of human blood lymphocytes and other reticulo-endothelial cells.

  1974cited by this paper
• Membrane ultrafiltration: the diafiltration technique and its application to microsolute exchange and binding phenomena.

  1968cited by this paper

• Liquid biopsy for monitoring of tumor dormancy and early detection of disease recurrence in solid tumors

  2023cites this paper
• Printing the Pathway Forward in Bone Metastatic Cancer Research: Applications of 3D Engineered Models and Bioprinted Scaffolds to Recapitulate the Bone–Tumor Niche

  2021cites this paper
• Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts

  2018cites this paper
• Disseminated tumor cells in bone marrow of cancer patients

  2015cites this paper
• Single cell transcriptomic analysis of prostate cancer cells

  2013cites this paper
• Changes in the location of oxytocin receptor in the human prostate

  2012cites this paper
• Isolated, disseminated and circulating tumour cells in prostate cancer

  2012cites this paper
• Redefining micrometastasis in prostate cancer - a comparison of circulating prostate cells, bone marrow disseminated tumor cells and micrometastasis: Implications in determining local or systemic treatment for biochemical failure after radical prostatectomy.

  2012cites this paper
• Micrometastasis: Detection methods and clinical importance

  2011cites this paper
• Expresión del supresor tumoral CD82 en células prostáticas primarias y secundarias en la circulación sanguínea (CPCs) de pacientes con cáncer prostático

  2010cites this paper
• CD82 tumor suppressor expression in primary and secondary circulating prostate cells (CPCs) in blood in patients with prost ate cancer

  2010cites this paper
• Curatively intended radiotherapy for prostate cancer Detection of disseminated tumor cells and long-term outcomes

  2009cites this paper
• Urokinase‐plasminogen‐activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer

  2009cites this paper
• Presence of prostate cells in bone marrow biopsies as a sign of micrometastasis in cancer patients.

  2009cites this paper
• Korrelation zwischen der Expression von MAGE-A Genen in disseminierten Tumorzellen und etablierten Prognosefaktoren bzw. dem Verlauf nach radikaler Prostatektomie beim lokal begrenzten Prostatakarzinom

  2008cites this paper
• Review: Biological relevance of disseminated tumor cells in cancer patients

  2008cites this paper
• Detection and characterization of circulating and disseminated prostate cancer cells.

  2007cites this paper
• Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy

  2007cites this paper
• Biology and clinical management of prostate cancer bone metastasis.

  2007cites this paper
• Chapter 14 – Immunohistology of the Prostate, Bladder, Testis and Kidney

  2006cites this paper
• Detection of Early Tumor Dissemination in Patients With Breast Cancer

  2006cites this paper
• Identifizierung und Charakterisierung metastatischer Vorläuferzellen aus dem Knochenmark beim Prostatakarzinom

  2006cites this paper
• Immunzytologische und regulatorische Untersuchungen der Ep-CAM Expression disseminierter Epithelzellen im Knochenmark von Mammakarzinom-Patientinnen

  2004cites this paper
• Detection, Isolation and Study of Disseminated Prostate Cancer Cells in the Peripheral Blood and Bone Marrow

  2003cites this paper
• Clinical approaches to osseous metastases in prostate cancer.

  2003cites this paper
• From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression

  2003cites this paper
• Prognosis of Minimal Residual Disease in Bone Marrow, Blood and Lymph Nodes in Breast Cancer

  2003cites this paper
• Analyse von Chromosomenaberrationen disseminierter Prostatakarzinomzellen im Knochenmark auf Einzelzellebene mittels einer kombinierten Immunzytochemie und Dreifarben Interphase Fluoreszenz-in-situ-Hybridisierung

  2003cites this paper
• Strategy against micrometastasis of epithelial cancer: Detection and elimination

  2002cites this paper
• Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.

  2002cites this paper
• Occult metastasis.

  2001cites this paper
• Detection of occult metastasis in patients with breast cancer.

  2001cites this paper
• Autoantibodies to Prostasomes as New Markers for Prostate Cancer

  2001cites this paper
• Minimal residual marrow disease: Detection and significance of isolated tumour cells in bone marrow

  2001cites this paper
• Bone marrow “micrometastases” of epithelial tumors: detection and clinical relevance

  2000cites this paper
• Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR.

  2000cites this paper
• Detection of minimal residual disease in patients with cancer: a review of techniques, clinical implications, and emerging therapeutic consequences.

  2000cites this paper
• The biology and analysis of single disseminated tumour cells.

  2000cites this paper
• Micrometastases of bone marrow in localized prostate cancer: correlation with established risk factors.

  1999cites this paper
• Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated.

  1998cites this paper
• Low frequency epithelial cells in bone marrow aspirates from prostate carcinoma patients are cytogenetically aberrant

  1998cites this paper
• Immunocytochemical monitoring of micrometastatic disease: Reduction of prostate cancer cells in bone marrow by androgen deprivation

  1997cites this paper
• Detection of micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer.

  1997cites this paper
• Immunocytologic staining of cytokeratin in bone marrow aspirates to detect micrometastatic cells fails in patients with metastatic urologic carcinoma.

  1997cites this paper
• Quality management and influential factors for the detection of single metastatic cancer cells by reverse transcriptase polymerase chain reaction.

  1997cites this paper
• Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate.

  1997cites this paper
• Gene expression changes associated with chemically induced rat mammary carcinogenesis

  1997cites this paper
• Micrometastasis detection and treatment with monoclonal antibodies.

  1996cites this paper
• Cytokeratin-positive cells in bone marrow for identifying distant micrometastasis of gastric cancer.

  1996cites this paper
• Minimal residual epithelial cancer: diagnostic approaches and prognostic relevance.

  1996cites this paper
• Detection of Minimal Disease in Patients with Solid Tumors

  1996cites this paper
• Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays.

  1994cites this paper